Argus Upgrades Teva to Buy, Cites Recent Drug Approvals
Teva Pharmaceutical Indus Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Teva Upgraded at J.P. Morgan on Upcoming Catalysts
Teva Pharmaceutical Indus Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
UBS Remains a Buy on Teva Pharmaceutical (TEVA)
Teva Pharmaceutical Indus Analyst Ratings
Barclays Remains a Buy on Teva Pharmaceutical (TEVA)
Teva Pharmaceutical Indus Analyst Ratings
BofA Securities Adjusts Teva Pharmaceutical Industries Price Target to $14 From $13, Maintains Buy Rating
Teva Pharmaceutical Indus Analyst Ratings
HSBC Initiates Coverage On Teva Pharmaceutical Indus With Buy Rating, Announces Price Target of $13
Teva Pharmaceutical Indus Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Alvotech Upgraded at Citi Citing FDA Nod for Biosimilars